Endothelial nitric oxide synthase: Correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer

Tumor Biology

Volumn 21, Issue 2, 2000, Pages 90-97

  Martin, Jan H J ^a   Begum, Shery ^a   Alalami, Osama ^a   Harrison, Adrian ^b   Scott, Kenneth W M ^b  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Estrogen receptor; Histologic grade; Nitric oxide; Nitric oxide synthase

Indexed keywords

ESTROGEN RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANTIBODY LABELING; ARTICLE; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; CORRELATION FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 0034006420     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030114     Document Type: Article

References (30)

1. Aoki E, Takeuchi IK, Shoji R: Nitric oxide: An attractive signalling molecule. Acta Histochem Cytochem 1995;28:97-106.
2. (1)-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 1991;266:6259-6263.
3. Forstermann U, Gath I, Schwarz P, Closs EI, Kleinert H: Isoforms of nitric oxide synthase: Properties, cellular distribution and expressional control. Biochem Pharmacol 1995;50:1321-1332.
4. Keller R, Geiges M, Keist R: L-Arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res 1990;50:1421-1425.
5. Weidner N, Folkman J, Pozza F, Pierantonio B, Allred EN, Moore DH, Meli S, Gasparini G: Tumour angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
6. Andrade SP, Hart HR, Piper PJ: Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 1992;107:1092-1097.
7. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW, Moncada S: Human colon cancer cell lines show a diverse pattern of nitric oxide synthase expression and nitric oxide generation. Br J Cancer 1994; 70:847-849.
8. 2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Biochem J 1993;289:357-361.
9. Alalami O, Martin JHJ: ZR-75-1 human breast cancer cells: Expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production. Cancer Lett 1998;123:99-105.
10. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in 1735 murine melanoma cells. Cancer Res 1994; 54:789-793.
11. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994;54:1352-1354.
12. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-44.
13. + monocytic cells in the tumor stroma. Int J Cancer 1985;35:199-205.
14. Martin JHJ, Edwards SW: Changes in mechanisms of monocyte/macrophage mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity whereas reactive nitrogen intermediates are employed by macrophages in tumour cell killing. J Immunol 1993;150: 3478-3486.
15. Martin JHJ, Alalami O, van den Berg HW: Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence. Cancer Lett, in press.
16. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
17. Kolb JP, Paul-Eugene N, Damais C, Yamaoka K, Drapier JC, Dugas B: Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem 1994;269:9811-9816.
18. Zembala M, Siedlar M, Marcinkiewicz J; Pryjma J: Human monocytes are stimulated for nitric oxide release in vitro by some tumour cells but not by cytokines and lipopolysaccharide. Eur J Immunol 1994;24: 435-439.
19. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumour-associated macrophages. Immunol Today 1992;13: 265-270.
20. Stuehr DJ, Nathan CF: Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J Exp Med 1989;169:1543-1555.
21. Drapier J, Hibbs JB Jr: Murine cytotoxic activated macrophages inhibit aconitase in tumour cells: Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 1986;78:790-795.
22. Granger DL, Taintor RR, Cook JL, Hibbs JB: Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest 1980;65:357-370.
23. Radomski MW, Jenkins DC, Holmes L, Moncada S: Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991;51: 6073-6078.
24. Sandoval M, Liu X, Oliver PD, Zhang XJ, Clark DA, Miller MJS: Nitric oxide induces apoptosis in a human colonic epithelial cell line, T84. Mediators Inflamm 1995;4: 248-250.
25. Cui S, Reichner JS, Mateo RB, Albina JE: Activated murine macrophages induce apoptosis in tumour cells through nitric oxide-dependent or independent mechanisms. Cancer Res 1994;54:2462-2467.
26. Orucevic A, Lala PK: NG-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br J Cancer 1996;73:189-196.
27. Zeillinger R, Tantscher E, Schneeberger C, Tschugguel W, Eder S, Sliutz G, Huber JC: Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res Treat 1996;40:205-207.
28. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, Shaul PW: Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 1997; 81:355-362.
29. Kauser K, Rubanyi GM: Potential cellular signalling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J Vase Res 1997;34:229-236.
30. Moncada S, Palmer RM: Biosynthesis and actions of nitric oxide. Semin Perinatol 1991;15:16-19.